Status:
UNKNOWN
The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
Cervical cancer the most frequent neoplasm and the third mortality rate of malignancies of the women in the world. It results in about 200,000 women dying of cervical cancer each year worldwide. The a...
Detailed Description
HPV and Cervical Cancers Human papillomaviruses (HPV) are small, nonenveloped DNA viruses which induce epithelial tumors of skin or mucosa. The majority of tumors are benign, show limited growth and u...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- normal volunteer, patients with CIN lesions or cervical cancers whose HLA haplotype is not HLA-A2
Exclusion
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00155792
Start Date
January 1 2002
End Date
December 1 2006
Last Update
December 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan